Polymorphic properties of micronized carbamazepine produced by RESS

被引:86
作者
Gosselin, PM
Thibert, R
Preda, M
McMullen, JN
机构
[1] Univ Montreal, Fac Pharm, Montreal, PQ, Canada
[2] Merck Frosst Canada & Co, Pharmaceut R&D, Kirkland, PQ, Canada
[3] Univ Quebec, Geotop, Montreal, PQ H3C 3P8, Canada
关键词
supercritical; carbon dioxide; polymorphism; carbamazepine; micronization;
D O I
10.1016/S0378-5173(02)00649-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Carbamazepine microparticles were produced by the rapid expansion of supercritical carbon dioxide solutions (RESS) method. The characteristics of the resulting particles were studied by X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), scanning electron microscopy (SEM) and image analysis. X-ray diffractograms and SEM photomicrographs revealed that the crystalline nature of the produced carbamazepine microparticles depended on operating pressure and temperature conditions. Different polymorphs were obtained under various operating conditions. Under certain temperature (below 40degreesC) and pressure (below 240 bar) conditions, it was possible to form primarily the carbamazepine polymorph stipulated by US Pharmacopeia. A significant reduction was observed in the particle size and size distribution range of carbamazepine produced by RESS. The processed particles had a mean diameter smaller than 3 mum and a size distribution range between 0.5 and 2.5 mum compared to unprocessed starting material with a mean diameter of approximately 85 mum and a size distribution range between 15 and 336 mum. Thus, this study demonstrates that the polymorphic characteristics of carbamazepine microparticles produced by the RESS method can be controlled by varying operating pressure and temperature parameters. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:225 / 233
页数:9
相关论文
共 29 条
[1]   HEAT OF FUSION MEASUREMENT OF A LOW MELTING POLYMORPH OF CARBAMAZEPINE THAT UNDERGOES MULTIPLE-PHASE CHANGES DURING DIFFERENTIAL SCANNING CALORIMETRY ANALYSIS [J].
BEHME, RJ ;
BROOKE, D .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1991, 80 (10) :986-990
[2]   Solubility and conversion of carbamazepine polymorphs in supercritical carbon dioxide [J].
Bettini, R ;
Bonassi, L ;
Castoro, V ;
Rossi, A ;
Zema, L ;
Gazzaniga, A ;
Giordano, F .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (03) :281-286
[3]  
Brittain H.G, 1995, PHYS CHARACTERIZATIO, P187
[4]   X-ray characterization of the triclinic polymorph of carbamazepine [J].
Ceolin, R ;
Toscani, S ;
Gardette, MF ;
Agafonov, VN ;
Dzyabchenko, AV ;
Bachet, B .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (09) :1062-1065
[5]   Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals [J].
Charoenchaitrakool, M ;
Dehghani, F ;
Foster, NR ;
Chan, HK .
INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH, 2000, 39 (12) :4794-4802
[6]  
DUGUE J, 1991, PHARM ACTA HELV, V66, P307
[7]   Crystallization of pure anhydrous polymorphs of carbamazepine by solution enhanced dispersion with supercritical fluids (SEDS™) [J].
Edwards, AD ;
Shekunov, BY ;
Kordikowski, A ;
Forbes, RT ;
York, P .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (08) :1115-1124
[8]   Smectite composition as a tracer of deep circulation: the case of the Northern North Atlantic [J].
Fagel, N ;
Robert, C ;
Preda, M ;
Thorez, J .
MARINE GEOLOGY, 2001, 172 (3-4) :309-330
[9]   Theoretical and experimental investigations of the micronization of organic solids by rapid expansion of supercritical solutions [J].
Helfgen, B ;
Türk, M ;
Schaber, K .
POWDER TECHNOLOGY, 2000, 110 (1-2) :22-28
[10]  
*ICDD, 1995, 331566 ICDD